Literature DB >> 7586693

Interactions and molecular structure of cardiolipin and beta 2-glycoprotein 1 (beta 2-GP1).

D Borchman1, E N Harris, S S Pierangeli, O P Lamba.   

Abstract

beta 2-GP1 is a serum protein which influences binding of anticardiolipin antibodies to cardiolipin, may influence induction of these antibodies in animals and may play a role in anticardiolipin-mediated thrombosis. Various investigators have proposed that when beta 2-GP1 binds cardiolipin, structural alterations occur in one or both molecules, resulting in exposure of new epitopes for anticardiolipin binding, but there has been no proof that such alterations occur. Utilizing Fourier transform infrared spectroscopy, this study analysed the structure of cardiolipin and beta 2-GP1 alone, then mixed with each other. For pure cardiolipin, analysis of the CH2 stretching, scissoring and carbonyl bands suggested this molecule assumes a hexagonal crystal lattice packing structure in both anhydrous and aqueous samples. Based on the second derivative analysis of the amide 1 band from the beta 2-GP1 protein backbone, as well as Fourier self-deconvolution and curve fit algorithms, beta 2-GP1 was calculated to contain 18% turns, 37% alpha-helix, and 45% beta-sheet structure. beta 2-GP1 binding with cardiolipin results in a significant change in the conformation as well as geometry of the lipid and protein components. This is indicated by a broadening of the CH stretching band and a marked shift in intensity of the carbonyl band of cardiolipin, indicating less hydrogen bonding. There was a decrease in beta-sheet structure of beta 2-GP1 from 46% to 23% and appearance of 26% to 28% random structure. These findings indicate that mixing beta 2-GP1 with cardiolipin results in profound changes in both molecules which might explain the effect of beta 2-GP1 on anticardiolipin binding activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7586693      PMCID: PMC1553418          DOI: 10.1111/j.1365-2249.1995.tb03792.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

Review 1.  Antiphospholipid antibodies.

Authors:  E N Harris
Journal:  Br J Haematol       Date:  1990-01       Impact factor: 6.998

2.  Protein secondary structures in water from second-derivative amide I infrared spectra.

Authors:  A Dong; P Huang; W S Caughey
Journal:  Biochemistry       Date:  1990-04-03       Impact factor: 3.162

Review 3.  Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance.

Authors:  P E Love; S A Santoro
Journal:  Ann Intern Med       Date:  1990-05-01       Impact factor: 25.391

4.  beta 2-Glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway.

Authors:  I Schousboe
Journal:  Blood       Date:  1985-11       Impact factor: 22.113

5.  Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).

Authors:  H P McNeil; R J Simpson; C N Chesterman; S A Krilis
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

6.  The structural specificity of anti-phospholipid antibodies in autoimmune disease.

Authors:  A S Janoff; J Rauch
Journal:  Chem Phys Lipids       Date:  1986 Jun-Jul       Impact factor: 3.329

7.  Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results.

Authors:  S Loizou; J D McCrea; A C Rudge; R Reynolds; C C Boyle; E N Harris
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

8.  Fourier transform infrared spectroscopy of 13C = O-labeled phospholipids hydrogen bonding to carbonyl groups.

Authors:  A Blume; W Hübner; G Messner
Journal:  Biochemistry       Date:  1988-10-18       Impact factor: 3.162

9.  Anticardiolipin antibodies: isotype distribution and phospholipid specificity.

Authors:  A E Gharavi; E N Harris; R A Asherson; G R Hughes
Journal:  Ann Rheum Dis       Date:  1987-01       Impact factor: 19.103

10.  Effects of the lupus anticoagulant in patients with systemic lupus erythematosus on endothelial cell prostacyclin release and procoagulant activity.

Authors:  M H Rustin; H A Bull; S J Machin; D A Isenberg; M L Snaith; P M Dowd
Journal:  J Invest Dermatol       Date:  1988-05       Impact factor: 8.551

View more
  10 in total

1.  Binding properties of antibodies to prothrombin and beta2-glycoprotein I (beta2-GPI) assayed by ELISA and dot blot.

Authors:  R R Forastiero; M E Martinuzzo; L O Carreras
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

2.  Conformationally altered beta 2-glycoprotein I is the antigen for anti-cardiolipin autoantibodies.

Authors:  L W Chamley; A M Duncalf; B Konarkowska; M D Mitchell; P M Johnson
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

3.  Apolipoprotein H, a new mediator in the inflammatory changes ensuring in jeopardised human myocardium.

Authors:  H W Niessen; W K Lagrand; H J Rensink; C J Meijer; L Aarden; C E Hack; C Visser
Journal:  J Clin Pathol       Date:  2000-11       Impact factor: 3.411

4.  Biophysical characterization of the recombinant chitinase chi18-5 with potential biotechnological interest.

Authors:  Martín Eduardo Villanueva; María Angel da Silva; José Luis Barra; Guillermo Gabriel Montich; Ismael Dario Bianco; Silvina R Salinas
Journal:  Appl Microbiol Biotechnol       Date:  2022-01-24       Impact factor: 4.813

5.  beta2-glycoprotein-I (apolipoprotein H) and beta2-glycoprotein-I-phospholipid complex harbor a recognition site for the endocytic receptor megalin.

Authors:  S K Moestrup; I Schousboe; C Jacobsen; J R Leheste; E I Christensen; T E Willnow
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

Review 6.  Ultraviolet-A1 irradiation therapy for systemic lupus erythematosus.

Authors:  H McGrath
Journal:  Lupus       Date:  2017-05-08       Impact factor: 2.911

Review 7.  Apolipoproteins and cancer.

Authors:  Liwen Ren; Jie Yi; Wan Li; Xiangjin Zheng; Jinyi Liu; Jinhua Wang; Guanhua Du
Journal:  Cancer Med       Date:  2019-10-01       Impact factor: 4.452

8.  Genetic dissection of quantitative trait Loci for hemostasis and thrombosis on mouse chromosomes 11 and 5 using congenic and subcongenic strains.

Authors:  Jane Hoover-Plow; Qila Sa; Menggui Huang; Jessica Grondolsky
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

9.  Biophysical analysis of the interaction of the serum protein human β2GPI with bacterial lipopolysaccharide.

Authors:  Anna Gries; Ruth Prassl; Satoshi Fukuoka; Manfred Rössle; Yani Kaconis; Lena Heinbockel; Thomas Gutsmann; Klaus Brandenburg
Journal:  FEBS Open Bio       Date:  2014-05-02       Impact factor: 2.693

10.  Human β-defensin 3 contains an oncolytic motif that binds PI(4,5)P2 to mediate tumour cell permeabilisation.

Authors:  Thanh Kha Phan; Fung T Lay; Ivan K H Poon; Mark G Hinds; Marc Kvansakul; Mark D Hulett
Journal:  Oncotarget       Date:  2016-01-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.